For hæmodialysepatienter i det sene stadie (end stage) af nyresygdom faldt AUC0- ∞ af total- aprepitant med 42% og Cmax faldt med 32%.
In patients with ESRD undergoing haemodialysis, the AUC0-∞ of total aprepitant decreased by 42% and Cmax decreased by 32%.